Biosenta Inc. reported earnings results for the first quarter ended December 31, 2022. For the first quarter, the company reported sales was CAD 0.000293 million compared to CAD 0.000292 million a year ago. Net loss was CAD 0.241843 million compared to CAD 0.548327 million a year ago.

Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.03 a year ago.